Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proposals to Redesign Medicare Part D

× No keyword cloud information.

9 in total

Review 1. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.

Authors: W Colby Brown; Brent Senior
Journal: Curr Allergy Asthma Rep Date: 2020-04-22 Impact factor: 4.806

2. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure.

Authors: Andrew Sumarsono; Muthiah Vaduganathan; Ezimamaka Ajufo; Ann Marie Navar; Gregg C Fonarow; Sandeep R Das; Ambarish Pandey
Journal: JAMA Cardiol Date: 2020-03-01 Impact factor: 14.676

3. Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs.

Authors: Daniel M Hartung; Kirbee A Johnston; Dennis N Bourdette; Randi Chen; Chien-Wen Tseng
Journal: Neurol Clin Pract Date: 2021-08

4. Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

Authors: Tianna Zhou; Patrick Liu; Sanket S Dhruva; Nilay D Shah; Reshma Ramachandran; Karina M Berg; Joseph S Ross
Journal: JAMA Intern Med Date: 2022-02-01 Impact factor: 44.409

5. Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population.

Authors: Daniel M Hartung; Kirbee A Johnston; Jessina C McGregor; Dennis N Bourdette
Journal: Int J MS Care Date: 2022-04-14

6. Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in EGFR- and ALK-Positive Advanced Non-Small-Cell Lung Cancer.

Authors: Bernardo H L Goulart; Joseph M Unger; Shasank Chennupati; Catherine R Fedorenko; Scott D Ramsey
Journal: JCO Oncol Pract Date: 2020-12-07

Proposals to Redesign Medicare Part D - Easing the Burden of Rising Drug Prices.

Review 1. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis.

2. Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure.

3. Closing the Part D Coverage Gap and Out-of-Pocket Costs for Multiple Sclerosis Drugs.

4. Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

5. Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population.

6. Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in EGFR- and ALK-Positive Advanced Non-Small-Cell Lung Cancer.

7. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.

8. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.

9. Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D.